Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

Clinical trial NCT06183931 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06183931
Sponsor: Alexion Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiomyopathy

Start date: 2024-01-11
Primary completion: 2027-12-06
Enrollment: 1181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.